EZH2 and neoplasm: Meanwhile, the EZH2-mediated target gene CCND1 was upregulated in the tumor (Figure S5C); CCND1 amplification is particularly common in ER-positive tumors and is associated with reduced survival in these patients [39,40,41,42,43].